Menu Search
Equities

Kingworld Medicines Group Ltd

1110:HKG

Kingworld Medicines Group Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)0.51
  • Today's Change0.00 / 0.00%
  • Shares traded628.00k
  • 1 Year change-31.08%
  • Beta0.8171
Data delayed at least 15 minutes, as of Sep 26 2024 08:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kingworld Medicines Group Ltd is an investment holding company primarily engaged in the distribution sale of branded imported pharmaceutical and healthcare products. The Company operates its business through two segments. The Distribution Sales of Pharmaceutical and Health Care Products segment engages in distribution and sales of branded imported pharmaceutical and healthcare products. The Company’s distribution products include Nin Jiom Pei Pa Koa, Taiko Seirogan, Culturelle Probiotics and other products. The Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices segment engages in the manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices. The Company’s medical devices and equipment products include infrared thermometers, handheld electrophysical therapeutic products and other products. The Company conducts its business in the domestic and overseas markets.

  • Revenue in HKD (TTM)1.16bn
  • Net income in HKD34.41m
  • Incorporated2008
  • Employees927.00
  • Location
    Kingworld Medicines Group Ltd10F, Block A, Tian An International BldgRenmin South RoadLuohu DistrictSHENZHEN 518016ChinaCHN
  • Phone+86 75 582292888
  • Fax+86 75 582170669
  • Websitehttps://www.kingworld.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.